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a b s t r a c t
Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) catalyzes the oxidation of L-dihydroorotate
to orotate with concomitant reduction of fumarate to succinate in the de novo pyrimidine biosynthetic
pathway. Based on the important need to characterize catalytic mechanism of TcDHODH, we have tai-
lored a protocol to measure TcDHODH kinetic parameters based on isothermal titration calorimetry.
Enzymatic assays lead to Michaelis–Menten curves that enable the Michaelis constant (KM) and maxi-
mum velocity (Vmax) for both of the TcDHODH substrates: dihydroorotate (KM = 8.6 ± 2.6 lM and
Vmax = 4.1 ± 0.7 lM s–1) and fumarate (KM = 120 ± 9 lM and Vmax = 6.71 ± 0.15 lM s–1). TcDHODH activity
was investigated using dimethyl sulfoxide (10%, v/v) and Triton X-100 (0.5%, v/v), which seem to facilitate
the substrate binding process with a small decrease in KM. Arrhenius plot analysis allowed the determi-
nation of thermodynamic parameters of activation for substrates and gave some insights into the enzyme
mechanism. Activation entropy was the main contributor to the Gibbs free energy in the formation of the
transition state. A factor that might contribute to the unfavorable entropy is the hindered access of sub-
strates to the TcDHODH active site where a loop at its entrance regulates the open–close channel for sub-
strate access.
 2009 Elsevier Inc. All rights reserved.
Chagas disease or American trypanosomiasis, caused by the ﬂa-
gellate protozoan parasite Trypanosoma cruzi, has been considered
one of the most neglected diseases in the world. The available con-
trol strategy has not fully helped to reduce disease burden. Despite
Brazil’s efforts to control this disease, a large segment of the pop-
ulation still suffers from its effects [1]. The most recent estimate
data from the Disease Control Priorities Project of the National
Institutes of Health and World Bank indicate an overall number
of 9.8 million people infected with T. cruzi [2].
The progression of this disease can lead to symptoms such as
inﬂammatory cardiomyopathy, neural disorders, and digestive
injuries. A large percentage of Chagas patients receive no speciﬁc
antiparasitic therapy because of the ineffectiveness and toxicity
of the pharmacological agents in use (nifurtimox and benznidaz-
ole). Hence, better therapeutic agents and novel drug targets need
to be developed, but when focusing on the challenges facing drug
target selection and characterization, care must be taken before
the search for active compounds can begin. This means that we
must, for instance, describe the biochemical mechanism of targets
to achieve active site complementarity (steric, electrostatic, and
hydrophobic).
Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH,1
EC 1.3.99.11) catalyzes a coupled redox reaction in which dihydro-
orotate (DHO) is oxidized to orotate and fumarate is reduced to suc-
cinate. This is the fourth enzymatic step in the pyrimidine de novo
biosynthetic pathway [3]. Although the enzymatic function of dihy-
droorotate dehydrogenases (DHODs) is conserved in all organisms,
the enzymes in prokaryotic and eukaryotic organisms are quite dif-
ferent [4].
Based on amino acid sequence identity, DHODs have been clas-
siﬁed into two families referred to as family 1 and family 2. Family
0003-2697/$ - see front matter  2009 Elsevier Inc. All rights reserved.
doi:10.1016/j.ab.2009.11.018
* Corresponding author. Address: Grupo de Química Medicinal de Produtos
Naturais, NEQUIMED–PN, Departamento de Química e Física Molecular, Instituto de
Química de São Carlos, Universidade de São Paulo, 13560-970 São Carlos, SP, Brazil.
Fax: +55 16 3373 9985.
E-mail address: montana@iqsc.usp.br (C.A. Montanari).
1 Abbreviations used: TcDHODH, Trypanosoma cruzi dihydroorotate dehydrogenase;
DHO, dihydroorotate; DHOD, dihydroorotate dehydrogenase; NAD+, nicotinamide
adenine dinucleotide; ITC, isothermal titration calorimetry; DMSO, dimethyl sulfox-
ide; IPTG, isopropyl b-D-thiogalactoside; Ni–NTA, nickel–nitrilotriacetic acid; SDS–
PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis; UV, ultraviolet;
HTS, high-throughput screening; FMN, ﬂavin mononucleotide.
Analytical Biochemistry 399 (2010) 13–22
Contents lists available at ScienceDirect
Analytical Biochemistry
journal homepage: www.elsevier .com/locate /yabio
1 DHODs are cytoplasmic enzymes further subdivided into families
1A and 1B. The TcDHODH belongs to the 1A homodimer enzymes
family that has fumarate as the reduced substrate, whereas the 1B
enzymes are heterotetramers that use nicotinamide adenine dinu-
cleotide (NAD+) as an oxidizing agent. Family 2 DHODs are mem-
brane-anchored enzymes that exist as monomers and use
quinones as oxidizing agents [5].
Several antitumor and immunosuppressive drugs act on human
DHOD. The two most promising drugs are brequinar (antitumor
and immunosuppressive) and leﬂunomide (immunosuppressive).
The latter has been Food and Drug Administration approved for
use in rheumatoid arthritis (Arava, Hoechst Marion Roussel). The
inhibition of DHODs causes a lowering of the intracellular pools
of the nucleotide bases uracil, cytosine, and thymine, making
DHODs attractive drug targets. In DHOD knockout studies, T. cruzi
did not express the enzyme protein and could not survive even in
the presence of pyrimidine nucleosides, conﬁrming its dependence
on de novo biosynthesis [6]. Because TcDHODH is a valid target, it
is of the utmost importance to elucidate its catalytic mechanism
and characterize its activity [7], thereby enabling the development
of a rapid and sensitive method to measure the inhibitory activity
of compounds.
Isothermal titration calorimetry (ITC) has been used in enzyme
kinetic assays to elucidate enzyme catalytic mechanisms and
determine Michaelis–Menten kinetic parameters [8]. The overall
principle of ITC is the measurement of heat ﬂow at constant tem-
perature. The rate at which heat is produced or absorbed can be re-
lated to the rate of conversion taking place in an enzymatic
reaction. The enzyme activity is monitored in real time without
the need for any probe [9]. Although ITC is used to study thermo-
dynamic properties of biological systems, this technique has not
been explored in depth as a means of investigating enzyme inhibi-
tion. ITC has an advantage over commonly used assay methods due
to its ability to detect heat changes during enzymatic conversion
under conditions such as poor transparency of solution with no
need for any chromogenic, ﬂuorogenic, or radioisotope-enriched
(labeled) ligands. Heat changes are fundamental during binding
events as well as biochemical reactions; thus, ITC is an ideal meth-
od for the characterization of enzyme reactions [10].
In this article, we describe for the ﬁrst time the determination of
TcDHODH enzyme kinetic parameters by ITC. We also measure the
inhibition constant and elucidate the mechanism of action of the
reaction product, orotate, to establish a response pattern of
TcDHODH when used to screen chemical substances. In addition,
kinetic experiments were carried out in the presence of the cosol-
vent dimethyl sulfoxide (DMSO) [11], a common solvent that en-
hanced the solubility of chemical compounds in water, and
Triton X-100, a nonionic surfactant used to prevent molecular
aggregation that frequently leads to false positives during screen-
ing assays. It is also important to measure the free energy, enthal-
py, and entropy of activation (DG#, DH#, and DS#, respectively) of
the enzymatic reaction to disclose the relative importance of the
enthalpic and entropic contributions of substrate to catalysis. A
description of the enzymatic transition state can be helpful in the
design of transition state analogs and in the search for inhibitors
with high afﬁnity for the enzyme TcDHODH.
Materials and methods
Materials
Reagents required for cloning, expression, and puriﬁcation of
TcDHODH
Isopropyl b-D-thiogalactoside (IPTG) was obtained from Invitro-
gen Life Technologies (São Paulo, Brazil). Nickel–nitrilotriacetic
acid (Ni–NTA) afﬁnity resin was obtained from Qiagen (Hilden,
Germany), and kanamycin antibiotic was obtained from Calbio-
chem (La Jolla, CA, USA). Protein standards used as sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) markers
were obtained from Sigma Chemical (St. Louis, MO, USA).
Chemical reagents required for enzyme kinetic assay
DHO, orotic acid (orotate), fumaric acid (fumarate), Trizma base,
and dibasic and monobasic sodium phosphate were purchased
from Sigma–Aldrich. Sodium chloride was obtained from Fluka.
Enzyme preparation
Recombinant TcDHODH was expressed and puriﬁed as de-
scribed elsewhere [12]. Brieﬂy, the puriﬁcation of the yellow en-
zyme TcDHODH (molecular mass of 34 kDa for the dimeric
protein) found in the soluble fraction was loaded onto a 2-mL col-
umn of Ni–NTA resin equilibrated with lysis buffer (50 mM sodium
phosphate [pH 8.0] and 300 mM NaCl). The column was then
washed with a step gradient of imidazole from 0 to 100 mM in lysis
buffer plus imidazole. The washes consisted of 40 mL of lysis buffer
with no imidazole followed by 50 mL of lysis buffer plus 25 mM
imidazole and then 10 mL of lysis buffer plus 50 mM imidazole.
The recombinant TcDHODH was eluted with approximately
20 mL of lysis buffer in the presence of 100 mM imidazole, and
purity was checked on 12% SDS–PAGE electrophoretic gels. Ultravi-
olet (UV) absorbance at 280 nm, based on tryptophan and tyrosine
residue molar extinction coefﬁcients, was used to estimate protein
concentration [13]. The extinction coefﬁcient calculated for the re-
combinant TcDHODH was 15,840 M–1 cm–1. Active fractions were
dialyzed at 4 C against phosphate-buffered saline (50 mM sodium
phosphate and 150 mM NaCl [pH 8.0]) and Tris-buffered saline
(20 mM Tris and 150 mM NaCl [pH 8.0]). The enzyme was concen-
trated with 10 kDa Amicon (Millipore) in Tris-buffered saline.
Determination of apparent enthalpy of reaction
The apparent molar enthalpy (DHapp) of conversion of DHO to
orotate by TcDHODH was determined by ITC as follows. The calo-
rimeter sample cell, with 1.43 mL, was loaded with Tris-buffered
saline (pH 8.0) containing 1.6 mM fumarate and 300 nM TcDHODH
and was titrated by a single injection of 10 lL from a syringe
loaded with 3.0 mM DHO in the same buffer. After a preliminary
equilibration period, when the instrument reached the tempera-
ture of 298 K, an additional 60-s delay period was allowed to gen-
erate the baseline. After this delay, the reaction was automatically
started by the injection of DHO with a heat reference at 25 lcal s–1.
The complete depletion of DHO and end of reaction were indicated
by the return of the instrumental thermal power to the baseline.
The stirring speed of the injection syringe was set to 307 rpm. Heat
ﬂow (microcalories per second) was recorded as a function of time.
The heat generated by dilution of the substrate was determined
under the same experimental conditions except for the absence
of enzyme [14]. The apparent molar enthalpy was then determined
by subtracting the heat of dilution from the total heat evolved dur-
ing the reaction and dividing by the number of DHOmoles injected
into the sample cell. The heat involved in the assay was found by
integrating the area under the heat ﬂow curve. The heat from buf-
fer ionization was checked by performing the apparent enthalpy
experiment under the same conditions but with a different buffer,
namely phosphate-buffered saline (pH 8.0).
Enzyme kinetics by ITC
Titration experiments were carried out with a VP-ITC calorime-
ter (MicroCal, Northampton, MA, USA) [15]. Solutions were de-
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gassed by means of a vacuum degasser (ThermoVac, MicroCal) and
thermostated for 5 min prior to any experimental run. A heating
reference of 25 lcal s–1 was used in all experiments. The heat ﬂow
released during the enzyme-catalyzed reaction was measured and
was found to be directly proportional to the rate of the reaction (V).
The relationships shown in Eqs. (1)–(3) below allow the kinetic
parameters maximal velocity, apparent catalytic constant, and
Michaelis constant (Vmax, k
app
cat , and KM, respectively) to be deter-
mined from a single ITC experiment. Although the VP-ITC calorim-
eter employed in this work is notmeant to be of use in high-throughput
screening (HTS), the results outlined here will be useful for those
who work in this very important area of enzyme inhibition. For
HTS results used to identify lead candidates for drug development,
an optimization algorithm based on enthalpic and entropic
information generated by ITC was put forward recently [16]. On
the other hand, it is noteworthy that using the new ITC200, a
throughput of up to 75 samples per day with a capacity to run
384 samples unattended is already at a hand.
V ¼ d½Pt
dt
¼ 1
DHappV0
dQ
dt
; ð1Þ
where [P]t is the instantaneous product concentration, V0 is the con-
stant volume of the sample cell (1.43 mL), and dQ/dt is the rate of
heat ﬂow measured during the experiment. The apparent molar en-
thalpy (DHapp) of the conversion of substrate to product is deter-
mined experimentally (see above).
The substrate concentration [S]t is calculated at any time using
the expression
½St ¼ ½S0 
R t
0
dQ
dt dt
V0DHapp
; ð2Þ
where [S]0 is the initial substrate concentration.
The kinetic parameters Vmax and KM were obtained by ﬁtting the
calorimetric data to the Michaelis–Menten equation [17] (Eq. (3))
using nonlinear least squares regression analysis:
V ¼ Vmax½St
KM þ ½St
: ð3Þ
Because the TcDHODH enzymatic catalysis is dependent on the
two substrates, DHO and fumarate, the assays were performed un-
der pseudo-ﬁrst-order conditions by using an excess of one sub-
strate and titrating the other. To follow the kinetic behavior of
DHO, a syringe was ﬁlled with the Tris-buffered saline (pH 8.0)
containing 3.0 mM DHO and the sample cell was ﬁlled with the
same buffer containing 1.6 mM fumarate and 50 nM TcDHODH en-
zyme. DHO was titrated by 20 injections of 1.0 lL. To analyze the
second substrate, 15 injections of 3.0 lL of fumarate (16 mM in
buffered solution) were titrated into the sample cell ﬁlled with
300 nM TcDHODH and 4 mM DHO in the same Tris-buffered saline.
These experiments were carried out at 298 K and a stirring speed of
307 rpm.
Spectrophotometric method for determination of TcDHODH reaction
The TcDHODH reaction was conventionally assayed in the spec-
trophotometer in parallel to the ITC method with 50 nM TcDHODH,
with the substrate DHO varying from 10 to 50 lM and fumarate in
excess (1.6 mM). A second assay was carried out with fumarate at
various concentrations ranging from 100 to 400 lM, DHO at 4 mM,
and TcDHODH at 300 nM. The reaction was started by injecting en-
zyme into the reaction mixture in Tris-buffered saline (pH 8.0) at
25 C (pH 8.0). Kinetic data were obtained by measuring the forma-
tion of the product orotate. The molar extinction coefﬁcient for
orotate at 300 nm used was 2650 M–1 cm–1.
Kinetic parameters and apparent enthalpy in the presence of cosolvent
and nonionic surfactant
TcDHODH enzyme activity was investigated in the presence of
organic cosolvent DMSO and the nonionic surfactant Triton X-
100. The isothermal titration experiments were carried out with
16 mM fumarate in the syringe and 300 nM TcDHODH and
4.0 mM DHO in the sample cell. All solutions were prepared in
Tris-buffered saline (pH 8.0). The substrate was titrated by 15
injections of 3.0 lL into the sample cell in the presence of DMSO
(10%, v/v) or Triton X-100 (0.5%, v/v) with an interval of 120 s be-
tween injections at 298 K. The reference power was 25 lcal s–1,
and the stirring speed was 307 rpm.
The molar apparent enthalpy (DHapp) of reaction was deter-
mined by ﬁlling the sample cell with 1.6 mM fumarate and
300 nM TcDHODH and ﬁlling the syringe with 3.0 mM DHO. The
reaction was buffered in 20 mM Tris and 150 mM NaCl (pH 8.0)
at a temperature of 298 K and was titrated by one injection of
10 ll in the presence of DMSO (10%, v/v) or Triton X-100 (0.5%,
v/v) (heat reference: 25 lcal s–1). Control experiments were carried
out in the absence of any cosolvent.
Enzyme inhibition by orotate
In the calorimetric TcDHODH inhibition assay, the syringe was
ﬁlled with 16 mM fumarate and the sample cell was ﬁlled with
4.0 mM DHO and 300 nM TcDHODH, with all solutions being pre-
pared in Tris-buffered saline (pH 8.0). Fumarate was titrated by 15
injectionsof3.0 lLat intervalsof120sata temperatureof298 K, ref-
erence power of 25 lcal s–1, and stirring speed of 307 rpm. A control
experimentwasperformed in theabsenceof orotate. To carryout the
enzyme inhibition evaluation by orotate, it was added to the sample
cell at varied concentrations of 50, 100, 200 and 300 lM.
Determination of thermodynamic reaction parameters of activation
The thermodynamic parameters of activation were carried out
by multiple injection titrations of each substrate into an excess
of the other in the presence of TcDHODH at 293, 298, 303, and
310 K. The ITC sample cell was ﬁlled with 1.6 mM fumarate and
50 nM TcDHODH enzyme, and 20 injections of 1.0 lL of DHO
(3.0 mM) solution were added to protein solution in the ITC cell
with 60-s interval monitoring and a stirring speed of 307 rpm.
The kinetic behavior of fumarate was then investigated by ﬁlling
the syringewith thebuffer solutioncontaining16 mMfumarate. The
sample cell was ﬁlledwith the buffered solution of 4.0 mMDHO and
300 nM TcDHODH. The experiments were carried out titrating the
fumarate by 15 injections of 3.0 lL with an interval between injec-
tions of 120 s, a stirring speed of 307 rpm, and temperatures at
293, 298, 303, and 310 K. An initial delay period of 60 s was allowed
to generate the baseline used in the subsequent data analyses. Heat
ﬂow (lcal s–1) was recorded as a function of time.
To deduce the temperature dependence of the reaction, kinetic
parameters were analyzed by making Arrhenius plots for temper-
atures ranging from 293 to 310 K. The activation energy (Ea) was
calculated from the slope (Ea/R) of the Arrhenius plot, and then
the thermodynamic activation parameters enthalpy (DH#), entro-
py (DS#), and Gibbs free energy (DG#) of activation were estimated
by the following equations [18]:
DH# ¼ Ea  RT; ð4Þ
DG# ¼ RTðlnðkB=hÞ þ ln T  ln kappcat Þ; ð5Þ
and
DS# ¼ ðDH#  DG#Þ=T; ð6Þ
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where energy values are in kJ mol–1, with kcat in s–1, to conform to
the units of the Boltzmann (1.3805  10–23 J K–1) and Planck
(6.6256  10–34 J s–1) constants and R is the gas constant
(8.314 J mol–1 K–1).
Data analysis
ITC raw data analyses of enthalpy of reaction were performed
with the graphic analysis program Origin 7.0, and the data repre-
senting the heat dilution effects, due to substrate dilution into
the buffer and mixing, were subtracted from the raw heat ﬂow
data [19]. Kinetic parameters were analyzed and calculated in
the enzyme assay mode of the program SigmaPlot 10.0.
Results
Apparent enthalpy of TcDHODH reaction
In ITC reaction experiments, the amount of heat exchanged is
proportional to the apparent molar enthalpy (DHapp). In this exper-
iment, a large amount of enzyme was placed in the sample cell to
ensure that all of the substrate was converted to product. DHO sub-
strate was chosen as the limiting reactant. The injection of 10 lL
led to a dilution of the DHO from 3.0 mM (syringe) to 21 lM (sam-
ple cell), whereas fumarate remained at a constant concentration
of 1.6 mM in the sample cell (Fig. 1).
Fig. 1 shows a typical calorimetric trace (heat ﬂow vs. time). The
output signal adopts negative values because it represents the var-
iation in the current feedback in the reference cell required to com-
pensate the heat released by the reaction in the sample cell. The
reaction goes to completion, allowing DHapp to be determined by
integrating the total peak area in the calorimeter trace. DHapp
was calculated with Eq. (7):
DHapp ¼ 1½StotV0
Z t
0
dQ
dt
: ð7Þ
The DHapp obtained was –11.64 ± 1.78 kcal mol–1 (from three
independent measurements). This DHapp value was used to calcu-
late the reaction rate (Eq. (1)) as described below.
Calorimetric determination of TcDHODH enzyme activity
The reaction rate depends on both fumarate and DHO concen-
trations, but it is describable in terms of pseudo-ﬁrst-order kinetics
when one of them is maintained in excess [14]. The enzyme activ-
ity was monitored for both substrates in separate experiments at
different concentrations. Initially, optimal concentrations of the
enzyme and substrate were determined by monitoring the conver-
sion of fumarate to succinate by TcDHODH via ITC. One require-
ment for an enzyme to operate via the Michaelis–Menten
mechanism is fulﬁlled when it reaches the steady-state condition,
where the concentration of the enzyme–substrate complex [ES] re-
mains constant at a given substrate concentration. Fig. 2 shows
raw data for thermal power plotted against time in the multiple
injection assays.
Steady-state conditions were veriﬁed in two different ways. The
ﬁrst way was to analyze the plateaus established between the
injections, where the concentration of intermediate [ES] remains
constant, when the rates of formation and breakdown of the com-
plex were equal. As a result, a well-deﬁned plateau was observed,
as shown in the inset of Fig. 2. The second way was to design an
experiment in which the amount of substrate was altered during
the time course of the reaction by injecting different volumes of
substrate (Fig. 3). If the reaction proceeds under steady-state con-
ditions, the kinetic parameters do not change. Kinetic parameters
are summarized in Table 1.
Fig. 4A shows the reaction rate dependence on DHO concentra-
tion, and Fig. 4B shows the reaction rate dependence on fumarate
concentration.
The kinetics of the DHOD-catalyzed enzyme reaction was ex-
plored by both UV–visible spectrophotometry and ITC. The two
experiments were carried out with the same solutions and enzyme
aliquots to minimize the differences due to operational errors and
variations in enzyme activity. The kinetic parameters determined
are of the same order of magnitude as those reported for the DHOD
family (Table 2).
Fig. 1. Heat ﬂow as a function of time (lcal s–1) for the oxidation of DHO to orotate
and the reduction of fumarate to succinate. The arrow corresponds to the substrate
injection and reaction start. The temperature was set to 298 K, and the instrument
thermal power was monitored until baseline return to initial value. DHO (3.0 mM)
in the syringe was titrated in a single injection of 10 ll into the sample cell
containing 1.6 mM fumarate and 300 nM TcDHODH. Buffer: 20 mM Tris and
150 mM NaCl (pH 8.0). The blue curve is the heat of substrate dilution under the
same conditions in the absence of TcDHODH. Reaction heat was subtracted from
the dilution event. (For interpretation of the reference to color in this ﬁgure legend,
the reader is referred to the Web version of this article.)
Fig. 2. ITC raw data for change in thermal power over time in the multiple injection
assay. As can be seen, dQ1/dt (heat ﬂow) is proportional to the heat released in the
sample cell. Under the conditions used, a steady state is reached when enzyme
velocity (power) remains constant. The arrow corresponds to the ﬁrst injection of
substrate into the sample cell. The experiment was performed at 298 K in Tris-
buffered saline, with 15 injections of 3.0 lL of 16 mM fumarate being titrated into
the sample cell ﬁlled with 300 nM TcDHODH and 4.0 mM DHO.
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Determination of enzyme activity in the presence of DMSO and Triton
X-100
The activity of TcDHODHwas observed in the presence of DMSO
and the surfactant Triton X-100. Table 3 summarizes the molar en-
thalpy (DHapp), Michaelis–Menten constant (KM), maximum veloc-
ity (Vmax), and catalytic efﬁciency (k
app
cat /KM) with fumarate
controlling the biochemical reaction.
Effect of orotate on TcDHODH reaction
The effect of product concentration on reaction mediumwas as-
sessed by determining the apparent inhibition constant (Kappi ) from
Fig. 5A. The rate of reaction (V) was measured at various concentra-
tions of orotate in the sample cell. The Lineweaver–Burk double re-
ciprocal plot is shown in Fig. 5B. The (Kappi obtained by nonlinear
least squares regression ﬁtted the experimental data to the model
for competitive inhibition, Eq. (8), using SigmaPlot 10.0 software:
V ¼ Vmax½S
½S þ KM 1þ ½IKi
  ; ð8Þ
where [I] is the inhibitor concentration.
The value of Vmax is constant at all inhibitor concentrations, but
the apparent value of KM (taken to be (1 + [I]/Ki)) increases with
inhibitor concentration. The effects are most apparent in the
0 150 300 450 600 750 900
0
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3
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 Volume change
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Fig. 3. Experimental veriﬁcation of steady state in reaction rate data. Red curve:
varying substrate volumes injected (5 injections of 3 ll and 3 injections each of 5, 7,
and 10 lL of 16 mM fumarate titrated into the sample cell ﬁlled with 300 nM
TcDHODH and 4 mM DHO in Tris-buffered saline (pH 8.0) at 298 K. Reference: 15
injections of 3 lL of 16 mM fumarate titrated into the sample cell ﬁlled with
300 nM TcDHODH and 4 mM DHO in Tris-buffered solution (pH 8.0). Velocity was
adjusted to a Michaelis–Menten equation. (For interpretation of the reference to
color in this ﬁgure legend, the reader is referred to the Web version of this article.)
Table 1
Kinetic parameters of steady-state experiment veriﬁcation.
KM (lM) Vmax (lM s–1)
Reference 120 ± 9 6.71 ± 0.15
Volume change 118 ± 3 6.42 ± 0.12
Fig. 4. Nonlinear least squares analyses of the experimental data to the Michaelis–
Menten equation to determine the kinetic parameters. The inset panel shows ITC
raw data for rate of heat ﬂow plotted against time in the multiple injection
titrations. (A) Total of 20 injections of 1.0 lL of 4.0 mM DHO into the sample cell
containing 16 mM fumarate and 50 nM TcDHODH (pH 8.0) at 298 K.
KM = 8.56 ± 2.6 lM. (B) Total of 15 injections of 3.0 lL of 16 mM fumarate titrated
into the sample cell ﬁlled with 300 nM TcDHODH and 4.0 mM DHO. Under these
conditions, product inhibition was thoroughly avoided. KM = 120 ± 9.0 lM.
Table 2
Comparison of KM values of family 1A of DHODs.
Species DHO (lM) Fumarate (lM) Method
Recombinant Trypanosoma
cruzi (Y strain)
8.56 ± 2.6 120 ± 9.0 ITC
12.9 ± 5.4 147 ± 17 UV
Leishmania major Friedlina 57.9 143 UV
Trypanosoma bruceib 14.0 80.0 UV
Lactococcus lactisc 35.0 ± 2.0 ND UV
Saccharomyces cerevisiaed 16.0 ± 5.0 115 ± 5.0 UV
Note. ND, not determined.
a The orotate production was measured spectrophotometrically at 300 nm
(e = 2.65 mM–1 cm–1) in a reaction mixture containing 50 mM Tris (pH 8.0) and
150 mM KCl with the substrates DHO and fumarate in a total volume of 1.0 mL at
25 C [20].
b Assays were performed in buffer (50 mM Hepes [pH 8.0], 150 mM NaCl, and
10% glycerol) at 25 C in the presence of 500 mM fumarate, and fumarate-depen-
dent activity was assayed in the presence of 250 mM DHO [21].
c Determined from orotate production by measuring absorption at various
wavelengths in 0.1 M potassium phosphate (pH 7.5) at 37 C [22].
d 1.0 mM DHO as substrate and 1.0 mM fumarate in 50 mM Tris–HCl, 150 mM
KCl, and 0.1% (v/v) Triton X-100 (pH 8.0) at 30 C by monitoring the increase in UV
absorption of the product orotate [23].
Table 3
Molar enthalpy, Michaelis–Menten constant, maximal velocity, and catalytic efﬁ-
ciency for fumarate-limited catalyzed reaction in the presence of DMSO and Triton X-
100.
Parametera Control 10.0% (v/v)
DMSO
0.5 % (v/v)
Triton X-100
DHapp
b (kcal mol–1) –11.64 ± 0.49 –10.73 ± 0.37 –10.81 ± 0.30
kappcat (s
–1) 20.5 16.5 13.6
Vmax (lM s–1) 6.16 ± 0.15 4.94 ± 0.10 4.04 ± 0.24
KM (lM) 120.00 ± 9.00 110.00 ± 7.39 84.70 ± 9.32
kappcat /KM 10
3(M–1 s–1) 171 150 160
a Kinetic parameter for TcDHODH (EC 1.3.99.11) enzyme determined as shown in
Fig. 4B for the substrate fumarate.
b The molar enthalpy values were determined separately, with typical DH values
for small molecule association to proteins in the range of 1–25 kcal mol–1
depending on the experimental conditions [24].
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double reciprocal plot (Fig. 5B), where the 1/Vmax intercept is con-
stant for all lines but their slopes (KM/Vmax) and x-intercept (–1/KM)
vary with inhibitor concentration.
Determination of thermodynamic parameters of activation
The activation energies of the TcDHODH reactions were calcu-
lated by determining the slope (–Ea/R) of the Arrhenius plots, and
the thermodynamic activation parameters at 298 K were estimated
from Eqs. (4)–(6) and are summarized in Table 4.
Modus operandi and control
The reaction began after the substrate injection, and the ITC
baseline then registered a negative deﬂection (Fig. 1), typical of
an exothermic reaction. A control experiment was done under
A
B
Fig. 5. Calorimetric TcDHODH assay in the presence of orotate. (A) Control experiment: 16 mM fumarate in the syringe, 4.0 mM DHO, and 300 nM TcDHODH in the
sample cell. All solutions were made up in Tris-buffered solution (pH 8.0), with fumarate titrated by 11 injections of 3.0 lL at intervals of 120 s and 298 K. The
reference power was 25 lcal s–1, and the stirring speed was 307 rpm. Inhibition experiment: in the sample cell, 50 lM orotate. (B) Double reciprocal plots obtained
at various orotate concentrations: 0 (control), 50, 100, 200, and 300 lM. A competitive nonlinear model was ﬁtted to data in the SigmaPlot program with
(Kappi = 110 ± 6.6 lM (from two independent measurements). The (K
app
i dimeric ﬁt is performed considering the total protein concentration as obtained by the
method of molar extinction coefﬁcient.
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the same reaction conditions but in the absence of enzyme to allow
the determination of the heat of dilution of the injected substrate
shown in the blue curve. The area above the peak of the black line
corresponds to the total heat (QT) released in the reaction. Solu-
tions in the syringe and in the sample cell were prepared in the
same buffer, pH, and salt concentration to minimize heat associ-
ated with dilution, diffusion, and mixture of solutions.
The reaction reached a maximum heat release at around
120 s, after which the signal gradually returned to the baseline.
The total depletion of limiting substrate took place at around
250 s, indicating the end of the reaction. The reaction heat was
subtracted from the dilution event (blue curve) and yielded
DHapp = –11.64 ± 1.78 kcal mol–1 (three independent measure-
ments). Thebufferprotonexchangeheatwas checkedbyperforming
the same measure runs in 50 mM sodium phosphate buffer, and no
changes inDHappwere observed (data not shown), suggesting as ex-
pected that there was no proton exchange with the buffer.
One requirement for an enzyme to operate through a Michae-
lis–Menten mechanism is that the steady-state condition should
be reached, where the concentration of the enzyme–substrate
complex [ES] remains constant at a given substrate concentration.
After the ﬁrst injection of fumarate, the reaction starts (Fig. 2
shows the raw data) and the baseline decreases from the initial le-
vel to a lower plateau that corresponds to the heat ﬂow according
to the reaction rate. The difference between the two plateaus is re-
lated to the velocity at a given substrate concentration (dQ/dt) [19].
Each injection increases the amount of limiting substrate in the
sample cell, so that the reaction rate increases and the baseline as-
sumes a new plateau at a lower level until enzyme saturation takes
place and the reaction velocity reaches its maximum.
Discussion
As can be seen in Fig. 3, the reaction catalyzed by TcDHODH en-
zyme is in the steady-state condition. Multiple injections of various
volumes, and consequently different concentrations of substrate
injected into the sample cell, did not alter the kinetic parameters
determined. A behavioral performance of TcDHODH reaction with
3 lL of fumarate injected into the sample cell was observed (Ta-
ble 1 and Fig. 3).
In Fig. 4A, to ensure a pseudo-ﬁrst-order reaction curve in rela-
tion to the substrate DHO, fumarate was present in excess, whereas
in Fig. 4B, the reaction curve is pseudo-ﬁrst order in relation to the
substrate fumarate.
DHO and fumarate had their Michaelis constants calculated by
ﬁtting the experimental velocity in the Michaelis–Menten equa-
tion, and their KM values were 8.6 ± 2.6 and 120 ± 9.0 lM, respec-
tively. Thus, DHO binds effectively to the enzyme active site at a
much lower concentration than fumarate, according to its small
KM value. Maximum velocities (Vmax) were calculated to be
4.1 ± 0.7 lM s–1 for DHO and 6.7 ± 0.1 lM s–1 for fumarate, but
DHO requires 14-fold lower concentration than fumarate to
achieve the Vmax.
Data in Table 2 are consistent with previous attempts to com-
pare ITC and established spectroscopic assays [25]. Analyzing the
UV and ITC methods in determining the Michaelis–Menten con-
stant, we observed ratios of 1.51 for the substrate DHO and 1.23
for the substrate fumarate. In this case, the kinetic parameters by
ITC and UV–visible spectroscopy agree well. Nevertheless, when
a difference occurs, we can infer that ITC can reveal parallel reac-
tions not detected by conventional assays [18].
The value of KM depends on the substrate and on environmental
conditions such as pH, temperature, ionic strength, and polarity,
and it provides a measure of the substrate concentration required
for signiﬁcant catalysis to occur.
Comparisons between methods and the kinetic parameters of
the 1A family of DHOD must be made carefully because experi-
mental conditions differ widely in terms of pH, buffer, substrate
concentration, and temperature [26]. High-quality kinetic data
are obtained by ITC because the rate of reaction is detected directly
and multiple injections of substrate are made automatically; fur-
thermore, ITC measurements do not depend on optical methods.
Kinetic parameters measured by microcalorimetry are accurate
and precise.
In this study, we also exposed the TcDHODH enzyme to DMSO
(10%, v/v) and Triton X-100 (0.5%, v/v) (Table 3), and as expected,
they did not affect the enthalpies of reaction. However, the maxi-
mum velocities using these concentrations along with all deﬁned
concentrations described in Materials and methods decreased to
80% in DMSO and to 66% in Triton X-100 when compared with
the control experiments. Both of them increase the hydrophobicity
of the solution, and this seems to facilitate the substrate binding
process; on the other hand, the catalytic efﬁciency decreases. At
lower KM values, the TcDHODH enzyme is more easily saturable
and, therefore, has a low Vmax.
After the establishment of a protocol to study the enzyme kinet-
ics by the ITC method, the product of the reaction TcDHODH, a
known inhibitor of the enzyme, was investigated by a new modus
operandi. The full enzymatic activity curve allowed the determina-
tion of the apparent inhibition constant (Kappi = 110 lM ± 6.6) as
well as the mechanism of inhibition in relation to the substrate
fumarate, both of which are essential in studies of structure–
activity relationships. The Lineweaver–Burk method was used to
derive the inhibition constant for orotate. The curve showed the
best ﬁt to the data in the competitive inhibition model (R2 = 0.97).
Thus, orotate competes for the same active site on the enzyme as
the substrates DHO and fumarate, and the formation of an enzyme–
inhibitor complex is possible. Thus, orotate can be used as a control
standard inhibitor during the screening of new compounds against
TcDHODH.
Knowledge of the enzyme–substrate transition structure pro-
vides fundamental information on the interactions occurring in
the reaction and provides a blueprint for the design of transition
state structure-based inhibitors [27].
In Fig. 6, we show a brief description of the transition state
structure based on the information in the literature, where ﬂavin
mononucleotide (FMN) is the prosthetic group [28,29].
Thecatalytic residueCys130withdrawsaproton fromDHOwhile
a hydride is transferred to FMN. In this step, the DHO is oxidized to
orotate and the FMNox is reduced to FMNred. The orotate is then re-
leased from the active site and the fumarate occupies its place.
FMN transfers the hydride to fumarate, converting it in succinate
while a proton is simultaneously abstracted from the Cys130 cata-
lytic group, reestablishing the enzyme for a new catalytic cycle.
Table 4
Thermodynamic activation parameters for the reaction catalyzed by TcDHODH at
298 K.
Parameter Fumarate DHO
kappcat
a 20.5 ± 1.6 45.0 ± 1.4
DG# (kcal mol–1) 15.6 ± 0.1 15.2 ± 0.1
DDG#b 0.4 0
Ea (kcal mol–1) 6.0 ± 0.3 3.0 ± 0.8
DEa 3.0 0
DH# (kcal mol–1) 5.5 ± 0.2 2.4 ± 0.8
DDH# 3.1 0
–TDS# (kcal mol–1) 10.1 ± 0.2 12.8 ± 0.1
–TDDS# –2.7 0
a kappcat is given in s
–1.
b DDG#, DEa, DDH#, and –TDDS# represent the differences between each pair of
values: TcDHODHfumarate – TcDHODHDHO.
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Thermodynamic parameters of this process were thoroughly
measured in this study. They are related to the differences between
the ground state (ES) and the activated enzyme–substrate complex
(ES#) for a hypothetical equilibrium, where the reagents only fol-
low through this state. It is important to recollect that the transi-
tion state theory contains several simpliﬁcations in describing a
complex phenomenon such as an enzymatic reaction, but the ther-
modynamic parameters derived from this description are helpful
in dissecting structure–reactivity relationships in the search for
transition state inhibitor analogs.
The values of DG# represent the energy barrier required for
reactions to occur. The DDG# value (Table 4) reveals the difference
of kappcat between the TcDHODH pseudo-ﬁrst-order catalyses of
fumarate and DHO. DG# is higher for the reduction of fumarate
than for the oxidation of DHO by 0.40 kcal mol–1, implying that
fumarate reduction is the rate-limiting step of the reaction cata-
lyzed by TcDHODH.
In the range of temperatures studied, no signiﬁcant variations in
DG#was observed, suggesting a similar overall process in the forma-
tion of the active complexbetween enzymeand substrates.DH# is of
Fig. 6. Catalytic mechanism illustrated to TcDHODH enzyme. First half-reaction: DHO oxidation via single transition state in which the active site has a Cys and a proton is
transferred to the ﬂavin cofactor. Second half-reaction: fumarate reduction.
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Fig. 7. Map of interactions between TcDHODH enzyme active site and substrates DHO and fumarate. Donor/Acceptor hydrogen patterns in agreement with calorimetric
results: the enzyme–DHO complex (A) has 10, whereas the enzyme–fumarate complex (B) has 6. Figures are taken from the PDB Sum databank with codes 2e68 and 2e6d
(http://www.ebi.ac.uk/pdbsum/2e68 and http://www.ebi.ac.uk/pdbsum/2e6d, respectively).
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the same order of magnitude as most reported values [30], andDS#
has themajor contribution to theDG# for both substrates. Activation
enthalpy is 1.8- and 5.3-fold less effective than the entropic energy
barriers of fumarate and DHO, respectively; the latter (>10 kcal -
mol–1) contributes unfavorably to the transition state.
To understand the enthalpy parameter, an analysis of the pro-
cess can be made in two different steps. The ﬁrst step is the binding
event between substrate and enzyme, which is favorable and has a
negative enthalpy (Table 3), and the second step is the formation of
the transition state. Comparative analyses of cocrystal structures
for the two substrates (PDB codes: 2e68 and 2e6d) show more
complementary interactions in the DHO–enzyme complex than
in the fumarate–enzyme complex (Fig. 7).
The fact that fumarate and DHO target the same active site al-
lows the two complex structures to be compared and correlated
with the thermodynamic activation parameters determined by
ITC. Fumarate has a more unfavorable activation enthalpy than
DHO (DDH# = 3.1 kcal mol–1), and this difference may be attrib-
uted to the smaller number of hydrogen bonds found; the en-
zyme–DHO complex has 10, whereas the enzyme–fumarate
complex has 6 (Fig. 7). Namely, the increase of rigidity of the
hydrogen-bonding pattern favors the enzyme–DHO complex sta-
bilization more than the enzyme–fumarate complex, and our ener-
getics data capture this properly. According to the structure-based
thermodynamic analysis, most of the enthalpically favorable inter-
actions are due to polar interactions established by Lys, Asn, and
Ser. The greater number of hydrogen interactions reﬂects favorably
in the binding enthalpic contribution for the formation of the ac-
tive complex when compared with the formation of the fuma-
rate–enzyme complex.
Unfavorable entropy might be associated with a decrease in
ﬂexibility of the system, loss of rotation, and translation of the sub-
strate molecule in the active complex. Another factor that might
contribute to the large unfavorable entropy is the accessibility of
each substrate to the TcDHODH active site; there is a loop at the
entrance to the active site located over the FMN cofactor on the
C-terminal end of the b-barrel that opens and closes the access
channel of the substrate to the active site [28]. During the binding
process of the formation of the DHO–enzyme active complex, there
is a signiﬁcantly greater loss of amino acid chain ﬂexibility relative
to the formation of the enzyme and the fumarate–enzyme active
complex, reﬂecting the more unfavorable entropic value.
Enzyme conformations are related to each molecule to occupy
an ensemble of conformation states. A change in temperature al-
ters the number of conformation states occupied by enzymes, di-
rectly interfering in the binding (substrate–enzyme) events.
Increasing the temperature, and consequently the number of con-
formation states occupied by enzymes, seems to lead to a decrease
in substrate afﬁnity.
An increaseof temperatureallowsan increase in thenumber con-
formational states available to the enzyme TcDHODH. Higher en-
zyme conformation mobility will lead to a large proportion of
enzyme molecules that will not bind to the substrate or will bind
poorly; consequently, it leads to an increase in KM values. This anal-
ysis agrees with the high unfavorable entropic contribution forDG#
[31].
Conclusions
A customized biochemical assay protocol based on ITC has
been employed for kinetic characterization of the TcDHODH en-
zyme reaction. These experiments demonstrated that ITC can be
reliably used to monitor reactions of this type routinely, easily,
and accurately with substrates and inhibitors that do not possess
any spectroscopic probes. Other attractive features of the method
are the ease and speed of the experiments. Enzyme assays are of-
ten laborious and time-consuming. The ITC method clearly de-
tects the substrate saturation phenomenon and can easily
record the enzyme activity in the steady state. If false positives
are a problem in bioassays, cosolvent DMSO and nonionic surfac-
tant Triton X-100 can be used to increase the solubility of small
molecule ligands and avoid the aggregation of molecules. The
method described in this article can allow the screening of com-
pounds as potential T. cruzi DHOD inhibitors that could be used
in Chagas disease chemotherapy. The product of the reaction, oro-
tate, was found to inhibit the TcDHODH enzyme at high concen-
tration in the mid-micromolar range and can be deﬁned as a
standard inhibitor for bioassays.
This study demonstrated that thermodynamic parameters im-
prove our understanding of enzymatic mechanisms. Beside this,
the transition statemodel elucidatedby the calorimetric determina-
tion of thermodynamic data reported here can help us to evaluate
the transition state of the reaction catalyzed by TcDHODH, and this
may orientate future research on the design of transition state
analogs.
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